Advertisement
U.S. markets open in 7 hours 47 minutes

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0065-0.0004 (-6.47%)
At close: 02:46PM EDT
Full screen
Add
Comparison
Indicators
Technicals
Corporate Events
Mountain
DrawTable View
Settings
AllAllFavoritesTextStatisticsTechnicalsFibonacciMarkingsLines
Loading interactive chart...
1D
Date Range
Interval:
1 min
  • CNW Group

    TSX Venture Exchange Stock Maintenance Bulletins

    TSX VENTURE COMPANIES

  • Newsfile

    PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

    PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization to manufacture biosynthetic tryptamines including PsyBio-11142 at scale Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon disco